Supernus' reliance on Qelbree is increasing, but generic competition for other drugs poses challenges. Read why I downgrade ...

Key Points Pharmaceutical stocks provide both safety and income during market turbulence. Bristol Myers Squibb offers an ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

Eli Lilly GLP-1 pill orforglipron could revolutionize the weight loss world by the end of 2025 after promising Phase 3 trial ...

Shares of Eli Lilly jumped 16% Thursday morning after the pharmaceutical company released clinical trial results for its oral ...

Generic drug manufacturers have had to contend with increasing competition and tight profit margins in recent years. Slapping extra costs through tariffs could undermine their ability to do ...

Photos of the drug busts showed Coast Guard officers boarding suspected drug smuggling vessels, including a narco-sub, to arrest suspects and seize the illegal narcotics on board. Ships ...

April 14 (UPI) --Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient ... At 1:30 p.m., Pfizer's stock was down 2 cents to $21.89.

Pfizer (PFE) announced early Monday that it is halting a late-stage trial of its GLP-1 pill candidate ... not enough to significantly impact the stock. Pfizer's stock traded mostly flat in ...

Shares of drugmakers were taking a broad beating Wednesday, after President Donald Trump indicated that pharmaceuticals will no longer be excluded from tariffs. Tomi Kilgore is MarketWatch's ...